SG47362A1 - Modified papilloma virus l2 protein and vlps formed thereform - Google Patents

Modified papilloma virus l2 protein and vlps formed thereform

Info

Publication number
SG47362A1
SG47362A1 SG1995001715A SG1995001715A SG47362A1 SG 47362 A1 SG47362 A1 SG 47362A1 SG 1995001715 A SG1995001715 A SG 1995001715A SG 1995001715 A SG1995001715 A SG 1995001715A SG 47362 A1 SG47362 A1 SG 47362A1
Authority
SG
Singapore
Prior art keywords
protein
papilloma virus
modified
virus
vlps formed
Prior art date
Application number
SG1995001715A
Other languages
English (en)
Inventor
Ian Frazer
Jian Zhou
Original Assignee
Univ Queensland
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland, Csl Ltd filed Critical Univ Queensland
Publication of SG47362A1 publication Critical patent/SG47362A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG1995001715A 1994-01-31 1995-01-31 Modified papilloma virus l2 protein and vlps formed thereform SG47362A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM3588A AUPM358894A0 (en) 1994-01-31 1994-01-31 Modified papilloma virus l2 protein and vlps formed therefrom

Publications (1)

Publication Number Publication Date
SG47362A1 true SG47362A1 (en) 1998-04-17

Family

ID=3778209

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995001715A SG47362A1 (en) 1994-01-31 1995-01-31 Modified papilloma virus l2 protein and vlps formed thereform

Country Status (12)

Country Link
US (1) US5993821A (ja)
EP (1) EP0750669B1 (ja)
JP (1) JP3417948B2 (ja)
KR (1) KR100353762B1 (ja)
AT (1) ATE226253T1 (ja)
AU (1) AUPM358894A0 (ja)
DE (1) DE69528578T2 (ja)
DK (1) DK0750669T3 (ja)
ES (1) ES2187551T3 (ja)
NZ (1) NZ279166A (ja)
SG (1) SG47362A1 (ja)
WO (1) WO1995020659A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
GB9806666D0 (en) * 1998-03-27 1998-05-27 Stanley Margaret Antigen preparation and use
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
AUPR446801A0 (en) 2001-04-18 2001-05-17 University Of Queensland, The Novel compositions and uses therefor
CA2741650C (en) * 2008-10-27 2017-09-05 Qiagen Gaithersburg Inc. Fast results hybrid capture assay and system
KR101873179B1 (ko) * 2009-08-26 2018-06-29 셀렉타 바이오사이언시즈, 인크. Ｔ－세포 도움을 유도하는 조성물
AU2011258501B2 (en) 2010-05-25 2016-07-07 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
CN113075992B (zh) * 2021-04-13 2022-07-05 浪潮电子信息产业股份有限公司 一种内存上电方法、装置、设备及计算机可读存储介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641081A1 (ja) * 1988-12-23 1990-06-29 Medgenix Group
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
SG48769A1 (en) * 1991-07-19 1998-05-18 Univ Queensland Papilloma virus vaccine
ES2263406T3 (es) * 1993-03-09 2011-06-06 The University Of Rochester Producción de la proteína de capside l1 del papilomavirus humano hpv-11 y partículas de tipo virus.
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines

Also Published As

Publication number Publication date
AUPM358894A0 (en) 1994-02-24
JPH09508273A (ja) 1997-08-26
NZ279166A (en) 1997-11-24
DK0750669T3 (da) 2003-02-24
ES2187551T3 (es) 2003-06-16
WO1995020659A1 (en) 1995-08-03
DE69528578D1 (de) 2002-11-21
EP0750669A1 (en) 1997-01-02
EP0750669A4 (en) 1998-05-27
KR100353762B1 (ko) 2002-12-26
EP0750669B1 (en) 2002-10-16
US5993821A (en) 1999-11-30
DE69528578T2 (de) 2003-07-17
ATE226253T1 (de) 2002-11-15
JP3417948B2 (ja) 2003-06-16

Similar Documents

Publication Publication Date Title
DE122011100018I1 (de) Herstellung von menschlichem Papilloma-Virus-Capsid-Protein und virusahnlichen Teilchen.
PL317234A1 (en) Vaccines against papilloma virus
WO1996011272A3 (de) Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung
ATE288489T1 (de) Vp-antigene des jc-virus
WO2003078455A3 (en) Virus like particle from papillomavirus and their use in vaccine
EA199700281A1 (ru) Молекула днк, кодирующая белок l1 вируса папилломы типа 11 чепловека, экспрессирующий вектор, способ получения очищенных вирусоподобных частиц
AU7545801A (en) Chimeric human papillomavirus (hpv) l1 molecules and uses therefor
SG47362A1 (en) Modified papilloma virus l2 protein and vlps formed thereform
CA2237807A1 (en) Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
WO1997004099A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
CA2182272A1 (en) Modified papilloma virus l2 protein and vlps formed therefrom
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
WO2003048299A3 (en) Novel spore wall proteins and genes from microsporidia
MX9701267A (es) Receptor de glutamato.